home / stock / nymx / nymx news


NYMX News and Press, Nymox Pharmaceutical Corporation From 12/06/22

Stock Information

Company Name: Nymox Pharmaceutical Corporation
Stock Symbol: NYMX
Market: NASDAQ
Website: nymox.com

Menu

NYMX NYMX Quote NYMX Short NYMX News NYMX Articles NYMX Message Board
Get NYMX Alerts

News, Short Squeeze, Breakout and More Instantly...

NYMX - Best Penny Stocks To Buy? 7 Under $1 To Watch Now

Penny Stocks Under $1 Penny stocks are stocks that trade for less than $5 per share. That’s the standard definition of penny stocks , at least. However, ask most traders in the stock market today, and they’ll set that price threshold much lower. In many cases, no matter ...

NYMX - Best Penny Stocks To Buy? 4 Under $1 To Watch Now

Penny Stocks Under $1 The basic definition of penny stocks includes those trading below $5. But if you ask most retail traders, they think of penny stocks as stocks trading for pennies a share. That means the vast majority are hunting for stocks under $1, and 2022 has been a year in which...

NYMX - NYMOX Announces New Marketing Submission for NYMOZARFEX(TM) for BPH

IRVINE, Calif., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce today that a new formal submission has been made by the Company in Europe for Fexapotide Triflutate for the treatment of benign prostatic hyperpla...

NYMX - May 2023 Market Cap Requirement Update

IRVINE, Calif., Nov. 25, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) reports that on November 18, 2022 the Company received a deficiency letter from NASDAQ stating the Listing Rules require listed securities to maintain and minimum ...

NYMX - Nymox gets FDA feedback on NDA resubmission for lead asset

Nymox Pharmaceutical ( NASDAQ: NYMX ), a biotech focused on drugs for the elderly, announced Tuesday that during the recent interactions, the FDA specified what additional information is required to resubmit a marketing application for its lead candidate Fexapotide. The co...

NYMX - Nymox Pharmaceutical up 37% as it assures shareholders company is well funded

Nymox Pharmaceutical has informed its shareholders that the company is well funded and its business plans are "on track." Shares are up 37% in morning trading. On Thursday, Nymox ( NASDAQ: NYMX ) received a non-compliance letter from Nasdaq . CEO Paul Averb...

NYMX - NYMOX Updates Shareholders

IRVINE, Calif., July 15, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced an update to its shareholders regarding progress in the Company business activities. Nymox wishes to assure our shareholders that business plans are continuing to be develo...

NYMX - NYMOX stock down 7.2% after receiving non-compliance letter from Nasdaq

Nymox Pharma ( NASDAQ: NYMX ) is down 7.2% after the company said it received a deficiency letter from Nasdaq stating that the company is no longer in compliance with Nasdaq. The company said it has 180 calendar days to regain compliance with the minimum bid price...

NYMX - NYMOX Receives Deficiency Letter from NASDAQ

IRVINE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) reports that on July 7, 2022 the Company received a deficiency letter from NASDAQ stating that the Company is no longer in compliance with Nasdaq Listing Rule 5550(a)(2). The Nasdaq letter...

NYMX - HIVE, XIN and NEON among mid-day movers

Gainers: Lixiang Education Holding (LXEH) +62%. GeoVax Labs (GOVX) +50%. Sonder Holdings (SOND) +30%. O2Micro International (OIIM) +30%. Evolving Systems (OTC:EVOL) +28%. GoldMining (GLDG) +27%. Neonode (NEON) +24%. Mesa Royalty Trust (MTR) +24%. TRxADE HEALTH (MEDS) +23%. Losers: HIVE Blockc...

Previous 10 Next 10